The Genetic Basis of Kidney Disease Risk in African Americans: MYH9 as a New Candidate Gene

American Journal of Kidney Diseases

Volumn 53, Issue 4, 2009, Pages 579-583

  Rao, Madhumathi ^a   Balakrishnan, V S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN HEAVY CHAIN;

AFRICAN AMERICAN; AGING; CAUCASIAN; CHROMOSOME 22; CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; EDITORIAL; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GLOMERULUS FILTRATION RATE; HAPLOTYPE; HERITABILITY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE; MICROALBUMINURIA; MYH9 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIOECONOMICS;

EID: 62749167021     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.02.005     Document Type: Editorial

References (45)

1. Bowden D.W. Genetics of kidney disease. Kidney Int Suppl 83 (2003) S8-S12
2. Freedman B.I., Spray B.J., Tuttle A.B., and Buckalew Jr. V.M. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21 (1993) 387-393
3. Lei H.H., Perneger T.V., Klag M.J., Whelton P.K., and Coresh J. Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol 9 (1998) 1270-1276
4. Fox C.S., Yang Q., Cupples L.A., et al. Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: The Framingham Heart Study. J Am Soc Nephrol 15 (2004) 2457-2461
5. Fox C.S., Yang Q., Guo C.Y., et al. Genome-wide linkage analysis to urinary microalbuminuria in a community-based sample: The Framingham Heart Study. Kidney Int 67 (2005) 70-74
6. Langefeld C.D., Beck S.R., Bowden D.W., Rich S.S., Wagenknecht L.E., and Freedman B.I. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 43 (2004) 796-800
7. Leon J.M., Freedman B.I., Miller M.B., et al. Genome scan of glomerular filtration rate and albuminuria: The HyperGEN study. Nephrol Dial Transplant 22 (2007) 763-771
8. US Renal Data System. USRDS 2006 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States (2006), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
9. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
10. Centers for Disease Control and Prevention. National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2003 (2003), US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
11. McClellan W., Tuttle E., and Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12 (1988) 285-290
12. Brancati F.L., Whittle J.C., Whelton P.K., Seidler A.J., and Klag M.J. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA 268 (1992) 3079-3084
13. Tarver-Carr M.E., Powe N.R., Eberhardt M.S., et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: A population-based study of potential explanatory factors. J Am Soc Nephrol 13 (2002) 2363-2370
14. Klag M.J., Whelton P.K., Randall B.L., Neaton J.D., Brancati F.L., and Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 277 (1997) 1293-1298
15. Cowie C.C., Port F.K., Wolfe R.A., Savage P.J., Moll P.P., and Hawthorne V.M. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321 (1989) 1074-1079
16. Toto R.D. Proteinuria and hypertensive nephrosclerosis in African Americans. Kidney Int Suppl 92 (2004) S102-S104
17. Fernandez M., Alarcon G.S., Calvo-Alen J., et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum 57 (2007) 576-584
18. Kitiyakara C., Eggers P., and Kopp J.B. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 44 (2004) 815-825
19. Kopp J.B., and Winkler C. HIV-associated nephropathy in African Americans. Kidney Int Suppl 83 (2003) S43-S49
20. US Renal Data System. USRDS 2008 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States (2008), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
21. Hsu C.Y., Lin F., Vittinghoff E., and Shlipak M.G. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14 (2003) 2902-2907
22. Satko S.G., Freedman B.I., and Moossavi S. Genetic factors in end-stage renal disease. Kidney Int Suppl 94 (2005) S46-S49
23. Reiner A.P., Ziv E., Lind D.L., et al. Population structure, admixture, and aging-related phenotypes in African American adults: The Cardiovascular Health Study. Am J Hum Genet 76 (2005) 463-477
24. Parra E.J., Marcini A., Akey J., et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 63 (1998) 1839-1851
25. Kao W.H., Klag M.J., Meoni L.A., et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40 (2008) 1185-1192
26. Kopp J.B., Smith M.W., Nelson G.W., et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40 (2008) 1175-1184
27. Nievergelt C.M., and Schork N.J. Admixture mapping as a gene discovery approach for complex human traits and diseases. Curr Hypertens Rep 7 (2005) 31-37
28. Smith M.W., and O'Brien S.J. Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet 6 (2005) 623-632
29. Darvasi A., and Shifman S. The beauty of admixture. Nat Genet 37 (2005) 118-119
30. Sellers J.R. Myosins: A diverse superfamily. Biochim Biophys Acta 1496 (2000) 3-22
31. Seri M., Pecci A., Di Bari F., et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 82 (2003) 203-215
32. Pezzolesi M.G., Poznik G.D., Mychaleckyj J.C., et al. Genome-wide association scan for diabetic nephropathy (DN) susceptibility genes in type 1 diabetes mellitus: Results from the Genetics of Kidneys in Diabetes (GoKinD) Collection. J Am Soc Nephrol 19 (2008) 57A (abstr)
33. Hwang S.J., Yang Q., Meigs J.B., Pearce E.N., and Fox C.S. A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet 8 suppl 1 (2007) S10
34. Kottgen A., Kao W.H., Hwang S.J., et al. Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med Genet 9 (2008) 49
35. Bowden D.W., Colicigno C.J., Langefeld C.D., et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int 66 (2004) 1517-1526
36. Freedman B.I., Langefeld C.D., Rich S.S., et al. A genome scan for ESRD in black families enriched for nondiabetic nephropathy. J Am Soc Nephrol 15 (2004) 2719-2727
37. Barisoni L., Schnaper H.W., and Kopp J.B. A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2 (2007) 529-542
38. Reich D., and Patterson N. Will admixture mapping work to find disease genes?. Philos Trans R Soc Lond B Biol Sci 360 (2005) 1605-1607
39. The Family Investigation of Nephropathy and Diabetes Research Group. Genetic determinants of diabetic nephropathy: The family investigation of nephropathy and diabetes (FIND). J Am Soc Nephrol 14 suppl 2 (2003) S202-S204
40. Freedman B.I., and Sedor J.R. Hypertension-associated kidney disease: Perhaps no more. J Am Soc Nephrol 19 (2008) 2047-2051
41. Freedman B.I., Kopp J.B., Winkler C.A., et al. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: The HyperGEN Study. Am J Nephrol 29 (2009) 626-632
42. Bamgboye E.L. End-stage renal disease in sub-Saharan Africa. Ethn Dis 16 (2006) S2-5-9
43. Barsoum R.S. Chronic kidney disease in the developing world. N Engl J Med 354 (2006) 997-999
44. Behar D.M., Shlush L.I., Maor C., Lorber M., and Skorecki K. Absence of HIV-associated nephropathy in Ethiopians. Am J Kidney Dis 47 (2006) 88-94
45. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 (2004) 2049-2057